AN2 Therapeutics Inc (ANTX) SEC filings
AN2 Therapeutics Inc (ANTX) SEC filings — 10-K, 10-Q, 8-K, and Form 4 as cached from EDGAR. When an exhibit lands, this page shows the headline, the numbers, and why it matters.
Those exhibit numbers sit next to the income-statement cache: Net income was -$26.5M. ANTX currently screens at market cap $32.0M. The ANTX filings page is the source view; the stock page is the research view.
EDGAR remains the official archive. Lician caches 8-K exhibits so you can read what AN2 Therapeutics Inc said without waiting on a live EDGAR scrape. Item 2.02 is the earnings exhibit — this page prefers EX-99.1 revenue, growth, EPS, and guidance over a form-type label. Form 4 insider prints stay on the same ticker timeline.
0
10-K
0
10-Q
0
8-K
0
Form 4
No cached SEC filings for ANTX yet. When an 8-K lands, this page will show the exhibit headline and numbers.
Open EDGAREDGAR is the official archive. Browse all ANTX filings.
Frequently asked questions
What did ANTX just say?
ANTX cached filings are listed below. Open the latest 8-K exhibit for the company’s own words.
Where are ANTX SEC filings?
0 cached filings are on this page. EDGAR remains the official archive.
What is an 8-K Item 2.02?
Item 2.02 is the earnings exhibit. Lician reads EX-99.1 for revenue, growth, EPS, and guidance — not a form-type label.